Tag: critical limb ischemia (CLI)

cell therapy

Cipla & Stempeutics collaborate for launch of Stempeucel

0
Cipla announced that its partner Stempeutics Research has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel...